{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:06:28Z","timestamp":1784664388062,"version":"3.55.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jcjd.2026.02.001","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:30:10Z","timestamp":1770395410000},"page":"234-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glaucocalyxin B Attenuates Diabetic Cardiomyopathy by Suppressing the NLRP3 Inflammasome and Restoring Gut Microbiota Homeostasis"],"prefix":"10.1016","volume":"50","author":[{"given":"Xinxin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2026.02.001_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jcjd.2026.02.001_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413228","article-title":"NLRP3 inflammasome in diabetic cardiomyopathy and exercise intervention","volume":"22","author":"Sun","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcjd.2026.02.001_bib3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: Preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jcjd.2026.02.001_bib4","article-title":"Endothelial dysfunction and diabetic cardiomyopathy","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcjd.2026.02.001_bib5","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jcjd.2026.02.001_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/hc1102.105289","article-title":"New concepts in diastolic dysfunction and diastolic heart failure: Part I: Diagnosis, prognosis, and measurements of diastolic function","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jcjd.2026.02.001_bib7","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/eurheartj\/ehr469","article-title":"Age-related effects of exercise training on diastolic function in heart failure with reduced ejection fraction: The Leipzig Exercise Intervention in Chronic Heart Failure and Aging (LEICA) Diastolic Dysfunction Study","volume":"33","author":"Sandri","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcjd.2026.02.001_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/2042018819834869","article-title":"Diabetic cardiomyopathy: Prevalence, determinants and potential treatments","volume":"10","author":"Gulsin","year":"2019","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2026.02.001_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1475-2840-8-58","article-title":"Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders","volume":"8","author":"Dinh","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jcjd.2026.02.001_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001902","article-title":"The inflammasome in atherosclerosis and type 2 diabetes","volume":"3","author":"Masters","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcjd.2026.02.001_bib11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.3389\/fphys.2018.01547","article-title":"The role of leukocytes in diabetic cardiomyopathy","volume":"9","author":"Bajpai","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.jcjd.2026.02.001_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jcjd.2026.02.001_bib13","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1021\/acs.jcim.5b00690","article-title":"Enhancing the enrichment of pharmacophore-based target prediction for the polypharmacological profiles of drugs","volume":"56","author":"Wang","year":"2016","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.jcjd.2026.02.001_bib14","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/jcp.27070","article-title":"Inhibition of JNK and p38 MAPK-mediated inflammation and apoptosis by ivabradine improves cardiac function in streptozotocin-induced diabetic cardiomyopathy","volume":"234","author":"Zuo","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jcjd.2026.02.001_bib15","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jcjd.2026.02.001_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104771","article-title":"NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model","volume":"9","author":"Luo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcjd.2026.02.001_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10557-013-6498-1","article-title":"Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model","volume":"28","author":"Luo","year":"2014","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jcjd.2026.02.001_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tiv.2010.09.006","article-title":"Glaucocalyxin A induces apoptosis in human leukemia HL-60 cells through mitochondria-mediated death pathway","volume":"25","author":"Gao","year":"2011","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.jcjd.2026.02.001_bib19","article-title":"Effect of traditional Chinese medicine on the cardiovascular diseases","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcjd.2026.02.001_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11255-023-03703-0","article-title":"Mechanisms and efficacy of traditional Chinese herb monomers in diabetic kidney disease","volume":"56","author":"Chen","year":"2024","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jcjd.2026.02.001_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jphs.2015.04.005","article-title":"Anti-inflammatory effects of glaucocalyxin B in microglia cells","volume":"128","author":"Gan","year":"2015","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jcjd.2026.02.001_bib22","doi-asserted-by":"crossref","first-page":"22544","DOI":"10.18632\/aging.203567","article-title":"Glaucocalyxin B inhibits cartilage inflammatory injury in rheumatoid arthritis by regulating M1 polarization of synovial macrophages through NF-\u03baB pathway","volume":"13","author":"Han","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jcjd.2026.02.001_bib23","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1159\/000485947","article-title":"Glaucocalyxin B alleviates lipopolysaccharide-induced Parkinson's disease by inhibiting TLR\/NF-\u03baB and activating Nrf2\/HO-1 pathway","volume":"44","author":"Xu","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jcjd.2026.02.001_bib24","doi-asserted-by":"crossref","first-page":"W609","DOI":"10.1093\/nar\/gkq300","article-title":"PharmMapper server: A web server for potential drug target identification using pharmacophore mapping approach","volume":"38","author":"Liu","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcjd.2026.02.001_bib25","doi-asserted-by":"crossref","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: A web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcjd.2026.02.001_bib67","doi-asserted-by":"crossref","first-page":"107144","DOI":"10.1016\/j.vascn.2021.107144","article-title":"Biochemical characterization of high fat diet fed and low dose streptozotocin induced diabetic Wistar rat model","volume":"113","author":"Wickramasinghe","year":"2022","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.jcjd.2026.02.001_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/jas\/skaa067","article-title":"Effects of dietary supplementation with exogenous catalase on growth performance, oxidative stress, and hepatic apoptosis in weaned piglets challenged with lipopolysaccharide","volume":"98","author":"Li","year":"2020","journal-title":"J Anim Sci"},{"key":"10.1016\/j.jcjd.2026.02.001_bib27","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.1093\/ilar.53.1.55","article-title":"Mice anesthesia, analgesia, and care. Part I: Anesthetic considerations in preclinical research","volume":"53","author":"Gargiulo","year":"2012","journal-title":"ILAR J"},{"key":"10.1016\/j.jcjd.2026.02.001_bib28","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1074\/jbc.M805329200","article-title":"Indomethacin, a non-steroidal anti-inflammatory drug, develops gastropathy by inducing reactive oxygen species-mediated mitochondrial pathology and associated apoptosis in gastric mucosa: A novel role of mitochondrial aconitase oxidation","volume":"284","author":"Maity","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcjd.2026.02.001_bib29","doi-asserted-by":"crossref","first-page":"35373","DOI":"10.1074\/jbc.M702175200","article-title":"NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways","volume":"282","author":"Abid","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcjd.2026.02.001_bib30","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1039\/C9FO00095J","article-title":"Ginsenoside Rk3 ameliorates high-fat-diet\/streptozocin induced type 2 diabetes mellitus in mice via the AMPK\/Akt signaling pathway","volume":"10","author":"Liu","year":"2019","journal-title":"Food Funct"},{"key":"10.1016\/j.jcjd.2026.02.001_bib68","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"Suppl.","key":"10.1016\/j.jcjd.2026.02.001_bib31","doi-asserted-by":"crossref","first-page":"770","DOI":"10.22270\/jddt.v9i3-s.2815","article-title":"Oral hypoglycemic drugs: An overview","volume":"9","author":"Kaur","year":"2019","journal-title":"J Drug Deliv Ther"},{"key":"10.1016\/j.jcjd.2026.02.001_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ackd.2019.08.004","article-title":"Toxicity of metformin and hypoglycemic therapies","volume":"27","author":"Akhter","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.jcjd.2026.02.001_bib33","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.fshw.2022.04.001","article-title":"Hypoglycemic natural products with in vivo activities and their mechanisms: A review","volume":"11","author":"Ma","year":"2022","journal-title":"Food Sci Hum Wellness"},{"key":"10.1016\/j.jcjd.2026.02.001_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112842","article-title":"Network pharmacology and metabolomics study on the intervention of traditional Chinese medicine Huanglian Decoction in rats with type 2 diabetes mellitus","volume":"258","author":"Pan","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jcjd.2026.02.001_bib35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2147\/CEOR.S266873","article-title":"Impact of weight change in adults with type 2 diabetes mellitus: A literature review and critical analysis","volume":"12","author":"Fridman","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.jcjd.2026.02.001_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pin.12868","article-title":"Inflammation in myocardial disease: From myocarditis to dilated cardiomyopathy","volume":"70","author":"Imanaka-Yoshida","year":"2020","journal-title":"Pathol Int"},{"key":"10.1016\/j.jcjd.2026.02.001_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5913374","article-title":"oxidative stress signaling mediated pathogenesis of diabetic cardiomyopathy","volume":"2022","author":"Tang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jcjd.2026.02.001_bib38","doi-asserted-by":"crossref","DOI":"10.1080\/13510002.2023.2246720","article-title":"Oxidative stress signaling in the pathogenesis of diabetic cardiomyopathy and the potential therapeutic role of antioxidant naringenin","volume":"28","author":"Xu","year":"2023","journal-title":"Redox Rep"},{"key":"10.1016\/j.jcjd.2026.02.001_bib39","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3390\/antiox11050934","article-title":"Glycolaldehyde, an advanced glycation end products precursor, induces apoptosis via ROS-mediated mitochondrial dysfunction in renal mesangial cells","volume":"11","author":"Gu","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jcjd.2026.02.001_bib40","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.3390\/ijms21144861","article-title":"Intracellular toxic advanced glycation end-products promote the production of reactive oxygen species in HepG2 cells","volume":"21","author":"Sakasai-Sakai","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcjd.2026.02.001_bib41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41580-022-00456-z","article-title":"Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology","volume":"23","author":"Sies","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jcjd.2026.02.001_bib42","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00726-022-03185-x","article-title":"N-acetyl-L-cysteine in human rheumatoid arthritis and its effects on nitric oxide (NO) and malondialdehyde (MDA): Analytical and clinical considerations","volume":"54","author":"Tsikas","year":"2022","journal-title":"Amino Acids"},{"key":"10.1016\/j.jcjd.2026.02.001_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2021.101515","article-title":"Chitosan oligosaccharides alleviate acute heat stress-induced oxidative damage by activating ERK1\/2-mediated HO-1 and GSH-Px gene expression in breast muscle of broilers","volume":"101","author":"Chang","year":"2022","journal-title":"Poult Sci"},{"key":"10.1016\/j.jcjd.2026.02.001_bib44","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10068-021-00914-y","article-title":"Antioxidant activity of \u03b2-cyclodextrin inclusion complexes containing trans-cinnamaldehyde by DPPH, ABTS and FRAP","volume":"30","author":"Jo","year":"2021","journal-title":"Food Sci Biotechnol"},{"key":"10.1016\/j.jcjd.2026.02.001_bib45","first-page":"1092","article-title":"Glaucocalyxin B relieving dyskinesia, inflammation and oxidative stress in Parkinson\u2019s disease model rats by activating the NRF2\/HO-1 pathway","volume":"85","author":"Lin","year":"2023","journal-title":"Indian J Pharm Sci"},{"key":"10.1016\/j.jcjd.2026.02.001_bib46","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1021\/acsomega.2c07913","article-title":"Determination of the anti-oxidative stress mechanism of Isodon suzhouensis leaves by employing bioinformatic and novel research technology","volume":"8","author":"Wang","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jcjd.2026.02.001_bib47","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3390\/antiox10060890","article-title":"NADPH oxidases (NOX): An overview from discovery, molecular mechanisms to physiology and pathology","volume":"10","author":"Vermot","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jcjd.2026.02.001_bib48","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1139\/cjpp-2019-0708","article-title":"Galectin-3 mediates high-glucose-induced cardiomyocyte injury by the NADPH oxidase\/reactive oxygen species pathway","volume":"98","author":"Sun","year":"2020","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.jcjd.2026.02.001_bib49","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.121.056589","article-title":"NAD+ metabolism in cardiac health, aging, and disease","volume":"144","author":"Abdellatif","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jcjd.2026.02.001_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167038","article-title":"NAD in pathological cardiac remodeling: Metabolic regulation and beyond","volume":"1870","author":"Norambuena-Soto","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jcjd.2026.02.001_bib51","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/eurheartj\/ehaa044","article-title":"NAD+ the disregarded molecule in cardiac metabolism","volume":"41","author":"Biefer","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcjd.2026.02.001_bib52","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2023.2220420","article-title":"The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease","volume":"45","author":"Chen","year":"2023","journal-title":"Ren Fail"},{"key":"10.1016\/j.jcjd.2026.02.001_bib53","first-page":"933","article-title":"Diagnostic sensitivity of creatine kinase-MB (CK-MB), cardiac troponin T (CTnT) and cardiac troponin I (CTnI) in acute myocardial infarction","volume":"6","author":"Shafiq","year":"2012","journal-title":"Pakistan J Med Health Sci"},{"key":"10.1016\/j.jcjd.2026.02.001_bib54","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.pcad.2020.03.001","article-title":"Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis","volume":"63","author":"Lippi","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jcjd.2026.02.001_bib55","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1038\/s41598-020-61894-3","article-title":"Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease","volume":"10","author":"Wu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcjd.2026.02.001_bib56","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1021\/acs.jmedchem.3c02412","article-title":"Cardiac troponin activator CK-963 increases cardiac contractility in rats","volume":"67","author":"Collibee","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.jcjd.2026.02.001_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2020.104319","article-title":"Total flavonoids extracted from the leaves of Murraya paniculata (L.) Jack alleviate oxidative stress, inflammation and apoptosis in a rat model of diabetic cardiomyopathy","volume":"76","author":"Zou","year":"2021","journal-title":"J Funct Foods"},{"key":"10.1016\/j.jcjd.2026.02.001_bib58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41387-024-00268-4","article-title":"Myricetin alleviates diabetic cardiomyopathy by regulating gut microbiota and their metabolites","volume":"14","author":"Zhu","year":"2024","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.jcjd.2026.02.001_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.842313","article-title":"Pyroptosis-related inflammasome pathway: A new therapeutic target for diabetic cardiomyopathy","volume":"13","author":"Cai","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcjd.2026.02.001_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1322907","article-title":"Role of pyroptosis in diabetic cardiomyopathy: An updated review","volume":"14","author":"Wang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcjd.2026.02.001_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/652097","article-title":"Potential role of nuclear factor \u03baB in diabetic cardiomyopathy","volume":"2011","author":"Lorenzo","year":"2011","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.jcjd.2026.02.001_bib62","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221083530","article-title":"Role of inflammation in diabetic cardiomyopathy","volume":"13","author":"Ramesh","year":"2022","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.jcjd.2026.02.001_bib63","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3790721","article-title":"The role of NLRP3 Inflammasome in diabetic cardiomyopathy and its therapeutic implications","volume":"2022","author":"Ding","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jcjd.2026.02.001_bib64","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fphys.2017.00519","article-title":"NLRP3 inflammasome as a molecular marker in diabetic cardiomyopathy","volume":"8","author":"Luo","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.jcjd.2026.02.001_bib65","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1111\/jcmm.13743","article-title":"Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation","volume":"22","author":"Zhang","year":"2018","journal-title":"J Cell Mol Med"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267126000298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267126000298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:33:03Z","timestamp":1784662383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267126000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1499267126000298"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2026.02.001","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glaucocalyxin B Attenuates Diabetic Cardiomyopathy by Suppressing the NLRP3 Inflammasome and Restoring Gut Microbiota Homeostasis","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2026.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Diabetes Canada.","name":"copyright","label":"Copyright"}]}}